MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) Q1 2024 Earnings Call Transcript

Page 6 of 6

Steve Daly: Thank you. Yes, you’re correct to say that LDMOS is part of the portfolio, and we will continue to provide those products to customer. We basically, when we visit customers and we look at requirements, it becomes clear through conversation what the best process technology is. And so we definitely have those conversations. And if LDMOS is more appropriate, then we’ll certainly offer that. We are not wedded to one over the other. And the 5G infrastructure, what you’re typically seeing is higher frequencies, you’re seeing requests for higher efficiency. And typically, GaN has the edge there. So that has been the trend over the past few years in this market. Now with that said, we MACOM our base makes MOSFETs and high-power devices in our fab here, silicon MOSFETs. And so we sell these products into avionics and a lot of defense systems, and we’ve been selling them for decades.

So we look at LDMOS as a great technology for avionics and some defense systems, some communication systems where they prefer that technology. And so we’ll actually be moving and focusing our sales force to sell LDMOS across all things wireless.

Operator: Thank you. And I’m showing no further questions at this time. I will now turn the call back over to Mr. Daly for any closing remarks.

Steve Daly: Thank you. In closing, I would like to thank our employees, suppliers and customers for making these results possible. As we move into 2024, we’re excited to service the RF and microwave markets with our bigger and stronger RF power team. We’re excited to be involved with cutting-edge data center applications for next-generation high-speed infrastructure and to service our growing SATCOM market. We will continue to work as a team to meet our customers needs and to execute our strategy. Thank you very much.

Operator: Ladies and gentlemen, that does conclude our conference for today. Thank you for your participation. You may now disconnect.

Follow Mts Medication Technologies Inc (NASDAQ:MTSI)

Page 6 of 6